BIOR.Q logo

Biora Therapeutics Stock Price

Symbol: OTCPK:BIOR.QMarket Cap: US$597.1kCategory: Pharmaceuticals & Biotech

BIOR.Q Share Price Performance

US$0.12
-6.11 (-98.15%)
US$0.12
-6.11 (-98.15%)
Price US$0.12

BIOR.Q Community Narratives

There are no narratives available yet.

BIOR.Q Community Fair Values

    Recent BIOR.Q News & Updates

    No updates

    Biora Therapeutics, Inc. Key Details

    US$892.0k

    Revenue

    US$0

    Cost of Revenue

    US$892.0k

    Gross Profit

    US$36.5m

    Other Expenses

    -US$35.6m

    Earnings

    Last Reported Earnings
    Sep 30, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -8.04
    Gross Margin
    100.00%
    Net Profit Margin
    -3,988.12%
    Debt/Equity Ratio
    -36.9%

    Biora Therapeutics, Inc. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About BIOR.Q

    Founded
    2010
    Employees
    58
    CEO
    Aditya Mohanty
    WebsiteView website
    www.bioratherapeutics.com

    Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California. On December 27, 2024, Biora Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

    U.S. Market Performance

    • 7 Days: -1.2%
    • 3 Months: 12.3%
    • 1 Year: 21.3%
    • Year to Date: 7.0%
    Over the past 7 days, the market has dropped 1.2% with the Consumer Discretionary sector contributing the most to the decline. In contrast to the last week, the market is actually up 21% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading